Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)

MARLBOROUGH, Mass.--(BUSINESS WIRE) June 12, 2018 --Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for apomorphine sublingual film (APL-130277) to...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news